|
XIST expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.184800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.369800E-01 |
| Normal-vs-Stage2 |
1.926200E-01 |
| Normal-vs-Stage3 |
8.000000E-01 |
| Normal-vs-Stage4 |
2.188600E-01 |
| Stage1-vs-Stage2 |
2.835000E-01 |
| Stage1-vs-Stage3 |
6.228400E-01 |
| Stage1-vs-Stage4 |
2.584100E-02 |
| Stage2-vs-Stage3 |
2.282600E-01 |
| Stage2-vs-Stage4 |
1.187030E-01 |
| Stage3-vs-Stage4 |
2.457600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.311800E-01 |
| Normal-vs-AfricanAmerican |
2.870400E-01 |
| Normal-vs-Asian |
7.623600E-01 |
| Caucasian-vs-AfricanAmerican |
5.071000E-01 |
| Caucasian-vs-Asian |
9.564400E-01 |
| AfricanAmerican-vs-Asian |
5.729000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.131880E-02 |
| Normal-vs-Female |
2.8181000000238E-06 |
| Male-vs-Female |
7.37420002838718E-09 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.563500E-02 |
| Normal-vs-Extreme_Weight |
6.146800E-01 |
| Normal-vs-Obese |
2.937600E-01 |
| Normal-vs-Extreme_Obese |
3.861600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.796100E-02 |
| Normal_Weight-vs-Obese |
5.800800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.268600E-01 |
| Extreme_Weight-vs-Obese |
1.805050E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.629400E-01 |
| Obese-vs-Extreme_Obese |
8.989600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.258400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.153600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.963000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.008600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.510200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.404000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.230600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.274600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.118200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.763200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.708200E-01 |
| Normal-VS-Type2 PRCC |
8.475800E-01 |
| Normal-VS-KIRP CIMP |
4.865800E-01 |
| Normal-VS-Unclassified PRCC |
5.141400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.116600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.363600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.460400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.584800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.516600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.338000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.918600E-01 |
| Normal-vs-N1 |
5.040000E-01 |
| Normal-vs-N2 |
7.850400E-01 |
| N0-vs-N1 |
4.605800E-01 |
| N0-vs-N2 |
8.206200E-01 |
| N1-vs-N2 |
6.431000E-01 |
|
|
